{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:23:18Z","timestamp":1792092198226,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.hoc.2011.02.003","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T18:46:11Z","timestamp":1301337971000},"page":"323-333","source":"Crossref","is-referenced-by-count":19,"title":["Thrombophilias in Pregnancy"],"prefix":"10.1016","volume":"25","author":[{"given":"E.M.","family":"Battinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.hoc.2011.02.003_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.003_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.AOG.0000172428.78411.b0","article-title":"Incidence and risk factors for stroke in pregnancy and the puerperium","volume":"106","author":"James","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.hoc.2011.02.003_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.105.576751","article-title":"Acute myocardial infarction in pregnancy: a United States population-based study","volume":"113","author":"James","year":"2006","journal-title":"Circulation"},{"issue":"9542","key":"10.1016\/j.hoc.2011.02.003_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(06)69380-X","article-title":"Maternal mortality: who, when, where, and why","volume":"368","author":"Ronsmans","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1471-0528.1997.tb11043.x","article-title":"An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy","volume":"104","author":"Macklon","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2003.09.057","article-title":"A\u00a0prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis","volume":"93","author":"Goldhaber","year":"2004","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0038-1648485","article-title":"Venous thrombosis during pregnancy: leg and trimester of presentation","volume":"67","author":"Ginsberg","year":"1992","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1067\/mob.2000.105405","article-title":"The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes","volume":"182","author":"Kovacevich","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1067\/mob.2001.107919","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study","volume":"184","author":"Danilenko-Dixon","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.003_bib12","first-page":"644","article-title":"Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and\/or intrauterine fetal growth retardation?","volume":"88","author":"Antovic","year":"2002","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.003_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)02734-6","article-title":"Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis","volume":"73","author":"Cerneca","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.003_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.003_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2141.2001.02766.x","article-title":"The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden","volume":"113","author":"Middeldorp","year":"2001","journal-title":"Br J Haematol"},{"issue":"6475","key":"10.1016\/j.hoc.2011.02.003_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.hoc.2011.02.003_bib19","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.92.10.2800","article-title":"Leiden and risks of recurrent idiopathic venous thromboembolism","volume":"92","author":"Ridker","year":"1995","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hoc.2011.02.003_bib20","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A\u00a0common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.003_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1067\/mob.2001.117304","article-title":"Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia","volume":"185","author":"Cotter","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.003_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0038-1657602","article-title":"The Leiden Thrombophilia Study (LETS)","volume":"78","author":"van der Meer","year":"1997","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000065076","article-title":"Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies","volume":"32","author":"Ray","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1067\/mob.2000.106820","article-title":"Genetic factors associated with thrombosis in pregnancy in a United States population","volume":"183","author":"Dilley","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2011.02.003_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.2010.05674.x","article-title":"Coagulation disorders in pregnancy: acquired and inherited thrombophilias","volume":"1205","author":"Benedetto","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-0378(97)00059-4","article-title":"Antiphospholipid antibodies and reproduction","volume":"35","author":"Kutteh","year":"1997","journal-title":"J\u00a0Reprod Immunol"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1646452","article-title":"The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study","volume":"66","author":"Long","year":"1991","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0002-9378(90)91176-D","article-title":"Epidemiology of preeclampsia and eclampsia in the United States, 1979\u20131986","volume":"163","author":"Saftlas","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.003_bib30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1365-2141.1996.410947.x","article-title":"HELLP syndrome associated with factor V R506Q mutation","volume":"92","author":"Brenner","year":"1996","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib31","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","article-title":"High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia","volume":"180","author":"van Pampus","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.hoc.2011.02.003_bib32","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00004872-200307000-00002","article-title":"Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis","volume":"21","author":"Kosmas","year":"2003","journal-title":"J\u00a0Hypertens"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.003_bib33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1160\/TH03-10-0637","article-title":"The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis","volume":"91","author":"Dudding","year":"2004","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.003_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.AOG.0000146250.85561.e9","article-title":"Genetic thrombophilias and preeclampsia: a meta-analysis","volume":"105","author":"Lin","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.hoc.2011.02.003_bib35","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1538-7836.2008.03134.x","article-title":"Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis","volume":"6","author":"Dudding","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000052998","article-title":"Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia","volume":"53","author":"D\u2019Elia","year":"2002","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.003_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3181c88918","article-title":"Prothrombin gene G20210A mutation and obstetric complications","volume":"115","author":"Silver","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.hoc.2011.02.003_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/plac.1999.0417","article-title":"Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review","volume":"20","author":"Ray","year":"1999","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.003_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0301-2115(01)00496-1","article-title":"How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review","volume":"101","author":"Alfirevic","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1160\/TH03-09-0596","article-title":"Maternal thrombophilias are not associated with early pregnancy loss","volume":"91","author":"Roque","year":"2004","journal-title":"Thromb Haemost"},{"issue":"9361","key":"10.1016\/j.hoc.2011.02.003_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.hoc.2011.02.003_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.003_bib44","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1055\/s-0037-1614367","article-title":"The risk of fetal loss in family members of probands with factor V Leiden mutation","volume":"82","author":"Tormene","year":"1999","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2011.02.003_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1309\/JWL27GRGU71VP5QL","article-title":"Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients","volume":"127","author":"Kocher","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2011.02.003_bib46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.thromres.2005.06.005","article-title":"Genetic prothrombotic risk factors in women with unexplained pregnancy loss","volume":"117","author":"Sottilotta","year":"2006","journal-title":"Thromb Res"},{"issue":"9032","key":"10.1016\/j.hoc.2011.02.003_bib47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.003_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0037-1616153","article-title":"Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism","volume":"86","author":"Simioni","year":"2001","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.hoc.2011.02.003_bib49","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 6","key":"10.1016\/j.hoc.2011.02.003_bib50","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0015-0282(02)04958-0","article-title":"Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage","volume":"79","author":"Hohlagschwandtner","year":"2003","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.hoc.2011.02.003_bib52","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2011.02.003_bib53","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2006.06480.x","article-title":"Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women","volume":"136","author":"Folkeringa","year":"2007","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2011.02.003_bib54","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1538-7836.2007.02586.x","article-title":"Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations","volume":"5","author":"Coppens","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7076","key":"10.1016\/j.hoc.2011.02.003_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.hoc.2011.02.003_bib56","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.003_bib57","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.003_bib58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"28","author":"Badawy","year":"2008","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.hoc.2011.02.003_bib59","doi-asserted-by":"crossref","first-page":"281.e1","DOI":"10.1016\/j.ajog.2008.10.021","article-title":"Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias","volume":"200","author":"Warren","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","article-title":"A\u00a0randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages","volume":"86","author":"Dolitzky","year":"2006","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.hoc.2011.02.003_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1538-7836.2009.03687.x","article-title":"Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review","volume":"8","author":"Mantha","year":"2010","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985881100013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985881100013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T17:45:05Z","timestamp":1592415905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985881100013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S088985881100013X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2011.02.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}